Human Lung S9 Fraction Mixed Gender

Kosheeka’s Human Lung S9 Fraction (Mixed Gender) represents an essential resource for researchers and scientists engaged in lung-related drug metabolism, pharmacokinetics, and toxicology studies.

+ Product Sheet
+ MSDS
+ PI

General Description

Kosheeka’s Human Lung S9 Fraction (Mixed Gender) represents an essential resource for researchers and scientists engaged in lung-related drug metabolism, pharmacokinetics, and toxicology studies. Derived from a diverse mix of male and female donors, this S9 fraction offers a comprehensive representation of drug-metabolizing enzymes present in lung tissues. Sourced from human lung tissue, it provides an authentic and physiologically relevant platform for in vitro investigations of drug metabolism within the lungs, enabling a deeper understanding of gender-specific responses and lung-specific pharmacokinetics. With meticulous purification and quality control processes, our Human Lung S9 Fraction (Mixed Gender) ensures the reliability and consistency needed for your research, facilitating advancements in pulmonary drug development and respiratory pharmacology research.